Related Experiment Video

Updated: May 15, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

322

Ginsenoside Rg5 inhibits the proliferation of HeLa cell through cell cycle pathway

Qianwen Mi1, Hang Sun1, Heyu Wang1

  • 1College of Food Science and Engineering, Jilin Agricultural University, Changchun, 130118 China.

Food Science and Biotechnology
|April 8, 2025
PubMed

Insights

Ginsenoside Rg5 significantly reduces key cell cycle proteins, including Minichromosome Maintenance Complex Component 6 (MCM6), in cervical cancer cells. This suggests MCM6 is a potential therapeutic target for cervical cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cervical cancer remains a leading cause of cancer death in women globally.
  • Ginsenoside Rg5's role in human cancer cell growth is recognized, but its precise mechanism of action is not well understood.
  • Understanding the molecular pathways affected by Ginsenoside Rg5 is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the preliminary mechanism of Ginsenoside Rg5 in cervical cancer.
  • To analyze the impact of Ginsenoside Rg5 on gene expression in HeLa cervical cancer cells.
  • To identify potential molecular targets for Ginsenoside Rg5-mediated cervical cancer treatment.

Main Methods:

  • Treatment of HeLa cells with Ginsenoside Rg5.
  • Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) to assess gene expression.
  • Western Blotting to evaluate protein levels.
  • RNA sequencing (RNA-seq) for comprehensive gene expression profiling.

Main Results:

  • Consistent down-regulation of cell cycle pathway proteins was observed across RT-qPCR, Western Blotting, and RNA-seq analyses.
  • Expression of Minichromosome Maintenance Complex Component 6 (MCM6), Cyclin A2 (CCNA2), Cyclin-dependent kinase 6 (CDK6), and Cell division cycle 6 (CDC6) was significantly reduced in treated HeLa cells.
  • Minichromosome Maintenance Complex Component 6 (MCM6) showed the most substantial inhibitory effect.

Conclusions:

  • Ginsenoside Rg5 treatment leads to a significant decrease in the expression of critical cell cycle regulators in cervical cancer cells.
  • The down-regulation of MCM6, CCNA2, CDK6, and CDC6 suggests Ginsenoside Rg5 interferes with cell cycle progression.
  • MCM6 emerges as a highly promising molecular target for the development of novel cervical cancer therapeutics.
Keywords:
Cell cycleCervical cancerGinsenoside Rg5MCM6RNA-seq

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.4K
HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis06:12

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

16.5K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.8K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K